Udit Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Udit Kumar has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Sudipta Seal
Advanced Materials Processing and Analysis Center, Nanoscience Technology Center, University of Central Florida, Orlando, FL 32826, USA
13 shared publications - Craig James Neal
Department of Materials Science and Engineering, University of Central Florida, Orlando, FL, USA
6 shared publications - Elayaraja Kolanthai
Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, Nanoscience Technology Center, Biionix Cluster, College of Medicine, University of Central Florida, Orlando, Florida, USA
6 shared publications Corbin Feit
Department of Materials Science and Engineering, University of Central Florida 1 , Orlando, Florida 32816
4 shared publications- Sushant Singh
Advanced Materials Processing and Analysis Center, University of Central Florida, 4000 Central Florida Blvd., P.O. Box 162455, Orlando, Florida 32816, USA
4 shared publications Elayaraja Kolanthai
Advanced Materials Processing and Analysis Center, Dept. of Materials Science and Engineering, University of Central Florida, Orlando, FL, USA
3 shared publications
Latest Publications
- Open Access
- 3 April 2024
- Published by American Vacuum Society in Journal of Vacuum Science & Technology A
- Vol. 42 (3)
Surface treatment of TaN for sub-2 nm, smooth, and conducting atomic layer deposition Ru films
Atomic layer deposition (ALD) of ruthenium (Ru) is being investigated for next generation interconnects and conducting liners for copper metallization. However, integration of ALD Ru with diffusion barrier refractory metal nitrides, such as tantalum nitride (TaN), continues to be a challenge due to its slow nucleation rates. Here, we demonstrate that an ultraviolet-ozone (UV-O3) pretreatment of TaN leads to an oxidized surface that favorably alters the deposition characteristics of ALD Ru from islandlike to layer-by-layer growth. The film morphology and properties are evaluated via spectroscopic ellipsometry, atomic force microscopy, electrical sheet resistance measurements, and thermoreflectance. We report a 1.83 nm continuous Ru film with a roughness of 0.19 nm and a sheet resistance of 10.8 KΩ/□. The interface chemistry between TaN and Ru is studied by x-ray photoelectron spectroscopy. It is shown that UV-O3 pretreatment, while oxidizing TaN, enhances Ru film nucleation and limits further oxidation of the underlying TaN during ALD. An oxygen “gettering” mechanism by TaN is proposed to explain reduced oxygen content in the Ru film and higher electrical conductivity compared to Ru deposited on native-TaN. This work provides a simple and effective approach using UV-O3 pretreatment for obtaining sub-2 nm, smooth, and conducting Ru films on TaN surfaces.
- 3 April 2024
- Published by American Vacuum Society in Journal of Vacuum Science & Technology A
- Vol. 42 (3)
Open AccessSurface treatment of TaN for sub-2 nm, smooth, and conducting atomic layer deposition Ru films
Atomic layer deposition (ALD) of ruthenium (Ru) is being investigated for next generation interconnects and conducting liners for copper metallization. However, integration of ALD Ru with diffusion barrier refractory metal nitrides, such as tantalum nitride (TaN), continues to be a challenge due to its slow nucleation rates. Here, we demonstrate that an ultraviolet-ozone (UV-O3) pretreatment of TaN leads to an oxidized surface that favorably alters the deposition characteristics of ALD Ru from islandlike to layer-by-layer growth. The film morphology and properties are evaluated via spectroscopic ellipsometry, atomic force microscopy, electrical sheet resistance measurements, and thermoreflectance. We report a 1.83 nm continuous Ru film with a roughness of 0.19 nm and a sheet resistance of 10.8 KΩ/□. The interface chemistry between TaN and Ru is studied by x-ray photoelectron spectroscopy. It is shown that UV-O3 pretreatment, while oxidizing TaN, enhances Ru film nucleation and limits further oxidation of the underlying TaN during ALD. An oxygen “gettering” mechanism by TaN is proposed to explain reduced oxygen content in the Ru film and higher electrical conductivity compared to Ru deposited on native-TaN. This work provides a simple and effective approach using UV-O3 pretreatment for obtaining sub-2 nm, smooth, and conducting Ru films on TaN surfaces.
- 18 March 2024
- Published by Elsevier in Biomaterials
- Vol. 307, 122527
A neoteric antibacterial ceria-silver nanozyme for abiotic surfaces
- 18 March 2024
- Published by Elsevier in Biomaterials
- Vol. 307, 122527
A neoteric antibacterial ceria-silver nanozyme for abiotic surfaces
- Open Access
- 2 November 2023
- Published by American Vacuum Society in Journal of Vacuum Science & Technology A
- Vol. 41 (6)
Real-time artificial intelligence enhanced defect engineering in CeO2 nanostructures
CeO2 nanostructures have been utilized for various biomedical, sensor, and catalysis applications owing to their unique defect structure, enabling them to have regenerative oxidative properties. Defect engineering in CeO2 nanostructures has major importance, enabling them to be utilized for specific applications. Despite various synthesis methods, it is challenging to have precise and reversible control over defect structures. Against this backdrop, in the current work, we have explored machine learning (ML) enhanced defect engineering of CeO2 nanofilms. In our earlier work [J. Vac. Sci. Technol. A 39, 060405 (2021)], we have developed an atomic layer deposition process for CeO2 using in situ ellipsometry measurements. In the current work, data collected through in situ spectroscopic ellipsometry and ex situ XPS have been correlated using two ML algorithms (gradient boost and random forest regressor) to exert better control over the chemical properties. Defect structures are one of the desired properties in CeO2 nanomaterials, characterized by the Ce3+/Ce4+ oxidation state ratio leading to its regenerative properties. We have shown that the defect structure of the CeO2 nanofilms can be predicted using in situ ellipsometry data in real time using a trained ML algorithm using two different methods. The first method involves an indirect approach of thickness prediction using an ML algorithm (k-nearest neighbors) followed by Ce3+/Ce4+ estimation using an experimental calibration curve. The second method with a more direct approach involves Ce3+/Ce4+ prediction using real-time ellipsometry data (amplitude ratio ψ and phase difference Δ) using gradient boost and random forest regressor.
- 2 November 2023
- Published by American Vacuum Society in Journal of Vacuum Science & Technology A
- Vol. 41 (6)
Open AccessReal-time artificial intelligence enhanced defect engineering in CeO2 nanostructures
CeO2 nanostructures have been utilized for various biomedical, sensor, and catalysis applications owing to their unique defect structure, enabling them to have regenerative oxidative properties. Defect engineering in CeO2 nanostructures has major importance, enabling them to be utilized for specific applications. Despite various synthesis methods, it is challenging to have precise and reversible control over defect structures. Against this backdrop, in the current work, we have explored machine learning (ML) enhanced defect engineering of CeO2 nanofilms. In our earlier work [J. Vac. Sci. Technol. A 39, 060405 (2021)], we have developed an atomic layer deposition process for CeO2 using in situ ellipsometry measurements. In the current work, data collected through in situ spectroscopic ellipsometry and ex situ XPS have been correlated using two ML algorithms (gradient boost and random forest regressor) to exert better control over the chemical properties. Defect structures are one of the desired properties in CeO2 nanomaterials, characterized by the Ce3+/Ce4+ oxidation state ratio leading to its regenerative properties. We have shown that the defect structure of the CeO2 nanofilms can be predicted using in situ ellipsometry data in real time using a trained ML algorithm using two different methods. The first method involves an indirect approach of thickness prediction using an ML algorithm (k-nearest neighbors) followed by Ce3+/Ce4+ estimation using an experimental calibration curve. The second method with a more direct approach involves Ce3+/Ce4+ prediction using real-time ellipsometry data (amplitude ratio ψ and phase difference Δ) using gradient boost and random forest regressor.
- Open Access
Broad-Spectrum, Potent, and Durable Ceria Nanoparticles Inactivate RNA Virus Infectivity by Targeting Virion Surfaces and Disrupting Virus–Receptor Interactions
There is intense interest in developing long-lasting, potent, and broad-spectrum antiviral disinfectants. Ceria nanoparticles (CNPs) can undergo surface redox reactions (Ce3+ ↔ Ce4+) to generate ROS without requiring an external driving force. Here, we tested the mechanism behind our prior finding of potent inactivation of enveloped and non-enveloped RNA viruses by silver-modified CNPs, AgCNP1 and AgCNP2. Treatment of human respiratory viruses, coronavirus OC43 and parainfluenza virus type 5 (PIV5) with AgCNP1 and 2, respectively, prevented virus interactions with host cell receptors and resulted in virion aggregation. Rhinovirus 14 (RV14) mutants were selected to be resistant to inactivation by AgCNP2. Sequence analysis of the resistant virus genomes predicted two amino acid changes in surface-located residues D91V and F177L within capsid protein VP1. Consistent with the regenerative properties of CNPs, surface-applied AgCNP1 and 2 inactivated a wide range of structurally diverse viruses, including enveloped (OC43, SARS-CoV-2, and PIV5) and non-enveloped RNA viruses (RV14 and feline calicivirus; FCV). Remarkably, a single application of AgCNP1 and 2 potently inactivated up to four sequential rounds of virus challenge. Our results show broad-spectrum and long-lasting anti-viral activity of AgCNP nanoparticles, due to targeting of viral surface proteins to disrupt interactions with cellular receptors.
Open AccessBroad-Spectrum, Potent, and Durable Ceria Nanoparticles Inactivate RNA Virus Infectivity by Targeting Virion Surfaces and Disrupting Virus–Receptor Interactions
There is intense interest in developing long-lasting, potent, and broad-spectrum antiviral disinfectants. Ceria nanoparticles (CNPs) can undergo surface redox reactions (Ce3+ ↔ Ce4+) to generate ROS without requiring an external driving force. Here, we tested the mechanism behind our prior finding of potent inactivation of enveloped and non-enveloped RNA viruses by silver-modified CNPs, AgCNP1 and AgCNP2. Treatment of human respiratory viruses, coronavirus OC43 and parainfluenza virus type 5 (PIV5) with AgCNP1 and 2, respectively, prevented virus interactions with host cell receptors and resulted in virion aggregation. Rhinovirus 14 (RV14) mutants were selected to be resistant to inactivation by AgCNP2. Sequence analysis of the resistant virus genomes predicted two amino acid changes in surface-located residues D91V and F177L within capsid protein VP1. Consistent with the regenerative properties of CNPs, surface-applied AgCNP1 and 2 inactivated a wide range of structurally diverse viruses, including enveloped (OC43, SARS-CoV-2, and PIV5) and non-enveloped RNA viruses (RV14 and feline calicivirus; FCV). Remarkably, a single application of AgCNP1 and 2 potently inactivated up to four sequential rounds of virus challenge. Our results show broad-spectrum and long-lasting anti-viral activity of AgCNP nanoparticles, due to targeting of viral surface proteins to disrupt interactions with cellular receptors.
- Open Access
- 15 November 2022
- Published by Royal Society of Chemistry (RSC) in Nanoscale Advances
- Vol. 5 (1) , 191-207
Assessing the bio-stability of microRNA-146a conjugated nanoparticles via electroanalysis
The stability of microRNA-146a conjugated with different nanoparticles in the presence of high oxidative stress was investigated through detailed electroanalysis.
- 15 November 2022
- Published by Royal Society of Chemistry (RSC) in Nanoscale Advances
- Vol. 5 (1) , 191-207
Open AccessAssessing the bio-stability of microRNA-146a conjugated nanoparticles via electroanalysis
The stability of microRNA-146a conjugated with different nanoparticles in the presence of high oxidative stress was investigated through detailed electroanalysis.
- 25 August 2022
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14 (36) , 40659-40673
Potent Inactivation of Human Respiratory Viruses Including SARS-CoV-2 by a Photoactivated Self-Cleaning Regenerative Antiviral Coating
The COVID-19 pandemic marks an inflection point in the perception and treatment of human health. Substantial resources have been reallocated to address the direct medical effects of COVID-19 and to curtail the spread of the virus. Thereby, shortcomings of traditional disinfectants, especially their requirement for regular reapplication and the related complications (e.g., dedicated personnel and short-term activity), have become issues at the forefront of public health concerns. This issue became especially pressing when infection-mitigating supplies dwindled early in the progression of the pandemic. In consideration of the constant threat posed by emerging novel viruses, we report a platform technology for persistent surface disinfection to combat virus transmission through nanomaterial-mediated, localized UV radiation emission. In this work, two formulations of Y2SiO5-based visible-to-UV upconversion nanomaterials were developed using a facile sol-gel-based synthesis. Our formulations have shown substantial antiviral activities (4 × 104 to 0 TCID50 units in 30 min) toward an enveloped, circulating human coronavirus strain (OC43) under simple white light exposure as an analogue to natural light or common indoor lighting. Additionally, we have shown that our two formulations greatly reduce OC43 RNA recovery from surfaces. Antiviral activities were further demonstrated toward a panel of structurally diverse viruses including enveloped viruses, SARS-CoV-2, vaccinia virus, vesicular stomatitis virus, parainfluenza virus, and Zika virus, as well as nonenveloped viruses, rhinovirus, and calicivirus, as evidence of the technology's broad antiviral activity. Remarkably, one formulation completely inactivated 105 infectious units of SARS-CoV-2 in only 45 min. The detailed technology has implications for the design of more potent, long-lived disinfectants and modified/surface-treated personal protective equipment targeting a wide range of viruses.
- 25 August 2022
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14 (36) , 40659-40673
Potent Inactivation of Human Respiratory Viruses Including SARS-CoV-2 by a Photoactivated Self-Cleaning Regenerative Antiviral Coating
The COVID-19 pandemic marks an inflection point in the perception and treatment of human health. Substantial resources have been reallocated to address the direct medical effects of COVID-19 and to curtail the spread of the virus. Thereby, shortcomings of traditional disinfectants, especially their requirement for regular reapplication and the related complications (e.g., dedicated personnel and short-term activity), have become issues at the forefront of public health concerns. This issue became especially pressing when infection-mitigating supplies dwindled early in the progression of the pandemic. In consideration of the constant threat posed by emerging novel viruses, we report a platform technology for persistent surface disinfection to combat virus transmission through nanomaterial-mediated, localized UV radiation emission. In this work, two formulations of Y2SiO5-based visible-to-UV upconversion nanomaterials were developed using a facile sol-gel-based synthesis. Our formulations have shown substantial antiviral activities (4 × 104 to 0 TCID50 units in 30 min) toward an enveloped, circulating human coronavirus strain (OC43) under simple white light exposure as an analogue to natural light or common indoor lighting. Additionally, we have shown that our two formulations greatly reduce OC43 RNA recovery from surfaces. Antiviral activities were further demonstrated toward a panel of structurally diverse viruses including enveloped viruses, SARS-CoV-2, vaccinia virus, vesicular stomatitis virus, parainfluenza virus, and Zika virus, as well as nonenveloped viruses, rhinovirus, and calicivirus, as evidence of the technology's broad antiviral activity. Remarkably, one formulation completely inactivated 105 infectious units of SARS-CoV-2 in only 45 min. The detailed technology has implications for the design of more potent, long-lived disinfectants and modified/surface-treated personal protective equipment targeting a wide range of viruses.
- Open Access
- 29 June 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (30) , 19327-19339
ALD based nanostructured zinc oxide coated antiviral silk fabric
The COVID-19 pandemic has underscored the importance of research and development in maintaining public health. Facing unprecedented challenges, the scientific community developed antiviral drugs, virucides, and vaccines to combat the infection within the past two years. However, an ever-increasing list of highly infectious SARS-CoV-2 variants (gamma, delta, omicron, and now ba.2 stealth) has exacerbated the problem: again raising the issues of infection prevention strategies and the efficacy of personal protective equipment (PPE). Against this backdrop, we report an antimicrobial fabric for PPE applications. We have fabricated a nanofibrous silk-PEO material using electrospinning followed by zinc oxide thin film deposition by employing the atomic layer deposition technique. The composite fabric has shown 85% more antibacterial activity than the control fabric and was found to possess substantial superoxide dismutase–mimetic activity. The composite was further subjected to antiviral testing using two different respiratory tract viruses: coronavirus (OC43: enveloped) and rhinovirus (RV14: non-enveloped). We report a 95% reduction in infectious virus for both OC43 and RV14 from an initial load of ∼1 × 105 (sample size: 6 mm dia. disk), after 1 h of white light illumination. Furthermore, with 2 h of illumination, ∼99% reduction in viral infectivity was observed for RV14. High activity in a relatively small area of fabric (3.5 × 103 viral units per mm2) makes this antiviral fabric ideal for application in masks/PPE, with an enhanced ability to prevent antimicrobial infection overall.
- 29 June 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (30) , 19327-19339
Open AccessALD based nanostructured zinc oxide coated antiviral silk fabric
The COVID-19 pandemic has underscored the importance of research and development in maintaining public health. Facing unprecedented challenges, the scientific community developed antiviral drugs, virucides, and vaccines to combat the infection within the past two years. However, an ever-increasing list of highly infectious SARS-CoV-2 variants (gamma, delta, omicron, and now ba.2 stealth) has exacerbated the problem: again raising the issues of infection prevention strategies and the efficacy of personal protective equipment (PPE). Against this backdrop, we report an antimicrobial fabric for PPE applications. We have fabricated a nanofibrous silk-PEO material using electrospinning followed by zinc oxide thin film deposition by employing the atomic layer deposition technique. The composite fabric has shown 85% more antibacterial activity than the control fabric and was found to possess substantial superoxide dismutase–mimetic activity. The composite was further subjected to antiviral testing using two different respiratory tract viruses: coronavirus (OC43: enveloped) and rhinovirus (RV14: non-enveloped). We report a 95% reduction in infectious virus for both OC43 and RV14 from an initial load of ∼1 × 105 (sample size: 6 mm dia. disk), after 1 h of white light illumination. Furthermore, with 2 h of illumination, ∼99% reduction in viral infectivity was observed for RV14. High activity in a relatively small area of fabric (3.5 × 103 viral units per mm2) makes this antiviral fabric ideal for application in masks/PPE, with an enhanced ability to prevent antimicrobial infection overall.
- 13 June 2022
- Published by Wiley in WIREs Nanomedicine and Nanobiotechnology
- Vol. 14 (5) , e1823
Antiviral nanopharmaceuticals: Engineered surface interactions and virus‐selective activity
The COVID‐19 pandemic has inspired large research investments from the global scientific community in the study of viral properties and antiviral technologies (e.g., self‐cleaning surfaces, virucides, antiviral drugs, and vaccines). Emerging viruses are a constant threat due to the substantial variation in viral structures, limiting the potential for expanded broad‐spectrum antiviral agent development, and the complexity of targeting multiple and diverse viral species with unique characteristics involving their virulence. Multiple, more infectious variants of SARS‐CoV2 (e.g., Delta, Omicron) have already appeared, necessitating research into versatile, robust control strategies in response to the looming threat of future viruses. Nanotechnology and nanomaterials have played a vital role in addressing current viral threats, from mRNA‐based vaccines to nanoparticle‐based drugs and nanotechnology enhanced disinfection methods. Rapid progress in the field has prompted a review of the current literature primarily focused on nanotechnology‐based virucides and antivirals. In this review, a brief description of antiviral drugs is provided first as background with most of the discussion focused on key design considerations for high‐efficacy antiviral nanomaterials (e.g., nanopharmaceuticals) as determined from published studies as well as related modes of biological activity. Insights into potential future research directions are also provided with a section devoted specifically to the SARS‐CoV2 virus.This article is categorized under: Toxicology and Regulatory Issues in Nanomediciney > Toxicology of Nanomaterials Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease Therapeutic Approaches and Drug Discovery > Nanomedicine for Respiratory Disease
- 13 June 2022
- Published by Wiley in WIREs Nanomedicine and Nanobiotechnology
- Vol. 14 (5) , e1823
Antiviral nanopharmaceuticals: Engineered surface interactions and virus‐selective activity
The COVID‐19 pandemic has inspired large research investments from the global scientific community in the study of viral properties and antiviral technologies (e.g., self‐cleaning surfaces, virucides, antiviral drugs, and vaccines). Emerging viruses are a constant threat due to the substantial variation in viral structures, limiting the potential for expanded broad‐spectrum antiviral agent development, and the complexity of targeting multiple and diverse viral species with unique characteristics involving their virulence. Multiple, more infectious variants of SARS‐CoV2 (e.g., Delta, Omicron) have already appeared, necessitating research into versatile, robust control strategies in response to the looming threat of future viruses. Nanotechnology and nanomaterials have played a vital role in addressing current viral threats, from mRNA‐based vaccines to nanoparticle‐based drugs and nanotechnology enhanced disinfection methods. Rapid progress in the field has prompted a review of the current literature primarily focused on nanotechnology‐based virucides and antivirals. In this review, a brief description of antiviral drugs is provided first as background with most of the discussion focused on key design considerations for high‐efficacy antiviral nanomaterials (e.g., nanopharmaceuticals) as determined from published studies as well as related modes of biological activity. Insights into potential future research directions are also provided with a section devoted specifically to the SARS‐CoV2 virus.This article is categorized under: Toxicology and Regulatory Issues in Nanomediciney > Toxicology of Nanomaterials Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease Therapeutic Approaches and Drug Discovery > Nanomedicine for Respiratory Disease
- 19 October 2021
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2021-02 (29) , 872
In-Situ Ellipsometry Aided Rapid ALD Process Development and Parameter Space Visualization
- 19 October 2021
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2021-02 (29) , 872
In-Situ Ellipsometry Aided Rapid ALD Process Development and Parameter Space Visualization